Filing Details
- Accession Number:
- 0001144204-14-066983
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-12 11:35:19
- Reporting Period:
- 2014-11-10
- Filing Date:
- 2014-11-12
- Accepted Time:
- 2014-11-12 11:35:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 810509 | Navidea Biopharmaceuticals Inc. | NAVB | In Vitro & In Vivo Diagnostic Substances (2835) | 311080091 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236444 | A Brendan Ford | 5600 Blazer Parkway, Suite 200 Dublin OH US 43017 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-10 | 11,446 | $1.32 | 170,696 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2014-11-10 | 10,000 | $1.03 | 180,696 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | P | Direct |
Footnotes
- Acquired from the Issuer in lieu of cash compensation for board and committee service during 3Q 2014.
Billionaire Hedge Funds
